What is the current Price Target for the Eliem Therapeutics Inc stock?

The average Eliem Therapeutics Inc target price is $4.50. This is -9.64% lower than the current stock price. The highest price target is 0.40%, the lowest is -19.68%. 2 Analysts have issued a price target Eliem Therapeutics Inc 2025 .

How high will the Eliem Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Eliem Therapeutics Inc stock will rise. The performance of stocks, including the Eliem Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Eliem Therapeutics Inc stock today?

The performance of Eliem Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Eliem Therapeutics Inc stock fall?

The decline in Eliem Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Eliem Therapeutics Inc Forecast, price target & analysts

$4.98

0.40% yesterday

Nasdaq, Sep 27, 10:00 pm CET

ISIN

US28658R1068

Symbol

ELYM

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Eliem Therapeutics Inc Target price 2024 - Analyst rating & recommendation

Eliem Therapeutics Inc Classifications & Recommendation:

Hold

100%

Eliem Therapeutics Inc Price Target

Target Price	$4.50
Price	$4.98
Deviation	9.64% register free of charge
Number of Estimates	2

	2 Analysts have issued a price target Eliem Therapeutics Inc 2025 . The average Eliem Therapeutics Inc target price is $4.50. This is 9.64% register free of charge lower than the current stock price. The highest price target is $5.00 0.40% register free of charge , the lowest is $4.00 19.68% register free of charge .
	A rating was issued by 1 analysts: 0 Analysts recommend Eliem Therapeutics Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Eliem Therapeutics Inc stock has an average upside potential 2025 of 9.64% register free of charge . Most analysts recommend the Eliem Therapeutics Inc stock at Hold.

Discover more stocks with a high price target

Valneva 193.41%

CureVac N.V. 166.83%

Evotec 97.18%

Plug Power Inc. 78.07%

Bavarian Nordic 35.24%

Volkswagen VZ 35.11%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now

The Apple stock at a glance with charts, current key metrics, news and stock analyses.

The Best Dividend Stocks in the Dividend Top Scorer list.

Stock Analyses of the Best Stocks Worldwide.

Start building wealth today